News

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
CDC panel expands RSV vaccine recommendations for at-risk adults aged 50-59, including Pfizer's Abrysvo. Read more here.
With the arrival of spring the most severe phase of the 2024-25 respiratory illness has officially come to an end, according to the Grant County Health District. "Since March 2025, emergency ...